Researchers developed an innovative approach -- demonstrated in mouse models and isolated human brain tissue -- to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases. The study introduces a first-of-its-kind blood-brain barrier-crossing conjugate (BCC) system, designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system (CNS).
source https://www.sciencedaily.com/releases/2024/11/241125125221.htm
Pharmaceuticals face 100% tariffs in US - unless firms strike a deal
-
The order does not affect generic medicines, the most commonly used in the
US.
source
https://www.bbc.com/news/articles/cx29kke01gpo?at_medium=RSS&at_camp...
23 hours ago
No comments:
Post a Comment